SCHOFIELD, Wis., Dec. 9, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS) announced today that it has recently scheduled air time for its first national direct response commercial featuring LipiGesic(TM) M, the Company's non-prescription medication for migraine headaches.
